Management and Executive

Group CEO and Managing Director

Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded

Telix Pharmaceuticals reports Q3 revenue $206M vs. $135M last year

Telix Pharmaceuticals raises FY25 revenue view to $800M-$820M from $770M-$800M

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance

Network Expansion Program Director

Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company dedicated to precision medicine through targeted radiation. The Network Expansion Program Director will establish guidance for the company's network expansion strategy, ensuring efficient execution of internal drug manufacturing capabilities while maintaining compliance with national regulatory standards.

Sign up with Google

Sign in with Google